BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28949028)

  • 1. CNS embryonal tumours: WHO 2016 and beyond.
    Pickles JC; Hawkins C; Pietsch T; Jacques TS
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):151-162. PubMed ID: 28949028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
    Cole BL; Pierson CR
    Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embryonal Tumors of the Central Nervous System: The WHO 2016 Classification and New Insights.
    Pinheiro JAF; de Almeida JCM; Lopes JMPB
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):79-89. PubMed ID: 32925406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in embryonal tumours of the central nervous system.
    Sarkar C; Deb P; Sharma MC
    Childs Nerv Syst; 2005 Apr; 21(4):272-93. PubMed ID: 15682321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical molecular pathology and histopathology of embryonal tumors.
    Phillips J; Tihan T; Fuller G
    Surg Pathol Clin; 2015 Mar; 8(1):73-88. PubMed ID: 25783823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors.
    Kamenova M; Kaneva R; Genova K; Gabrovsky N
    Adv Exp Med Biol; 2023; 1405():225-252. PubMed ID: 37452940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryonal tumors in the WHO CNS5 classification: A Review.
    Gianno F; Miele E; Antonelli M; Giangaspero F
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonal Tumors of the Central Nervous System: An Update.
    Blessing MM; Alexandrescu S
    Surg Pathol Clin; 2020 Jun; 13(2):235-247. PubMed ID: 32389264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives.
    Shih RY; Koeller KK
    Radiographics; 2018; 38(2):525-541. PubMed ID: 29528832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).
    Cotter JA; Judkins AR
    Pediatr Dev Pathol; 2022; 25(1):34-45. PubMed ID: 35168419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours.
    Alexandrescu S; Paulson V; Dubuc A; Ligon A; Lidov HG
    Histopathology; 2018 Sep; 73(3):483-491. PubMed ID: 29758594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
    Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
    World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.
    Schepke E; Löfgren M; Pietsch T; Kling T; Nordborg C; Olsson Bontell T; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sabel M; Lannering B; Carén H
    Clin Epigenetics; 2023 Mar; 15(1):40. PubMed ID: 36895035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities.
    Korshunov A; Jakobiec FA; Eberhart CG; Hovestadt V; Capper D; Jones DT; Sturm D; Stagner AM; Edward DP; Eagle RC; Proia AD; Koch A; Ryzhova M; Ektova A; Schüller U; Zheludkova O; Lichter P; von Deimling A; Pfister SM; Kool M
    Neuropathology; 2015 Dec; 35(6):538-44. PubMed ID: 26183384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Items (tumors) worthy of special mention in the proposed new WHO histological classification of tumors of the central nervous system].
    Ishida Y
    No To Shinkei; 1994 Dec; 46(12):1127-32. PubMed ID: 7893529
    [No Abstract]   [Full Text] [Related]  

  • 16. Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.
    Gojo J; Kjaersgaard M; Zezschwitz BV; Capper D; Tietze A; Kool M; Haberler C; Pizer B; Hoff KV
    Eur J Med Genet; 2023 Jan; 66(1):104660. PubMed ID: 36356895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models of CNS embryonal tumors.
    Momota H; Holland EC
    Brain Tumor Pathol; 2009; 26(2):43-50. PubMed ID: 19856214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
    Komori T
    Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology of paediatric central nervous system tumours.
    Chiang JC; Ellison DW
    J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of posterior fossa tumours in children: new insights.
    D'Arco F; Khan F; Mankad K; Ganau M; Caro-Dominguez P; Bisdas S
    Pediatr Radiol; 2018 Dec; 48(13):1955-1963. PubMed ID: 30120502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.